Ingevity Corp (NGVT) stock
NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3076% above fair value
$59.28−0.74 (-1.23%)
Close on Nov 17, 2026Market cap $2.04BP/E 40.3Yield –
Ingevity operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Ingevity's operating cash flow for the twelve months ending Jun 30, 2026 was $211.00M, down 2.0% year over year. For fiscal 2025 it was $331.20M, up 157.5% from the year before. Over ten years it grew 16.5% a year on average. The highest annual figure on record is $352.40M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $331.20M | +157.5% |
| FY2024 | Dec 31, 2024 | $128.60M | -37.3% |
| FY2023 | Dec 31, 2023 | $205.10M | -34.6% |
| FY2022 | Dec 31, 2022 | $313.40M | +6.9% |
| FY2021 | Dec 31, 2021 | $293.30M | -16.8% |
| FY2020 | Dec 31, 2020 | $352.40M | +27.8% |
| FY2019 | Dec 31, 2019 | $275.70M | +9.4% |
| FY2018 | Dec 31, 2018 | $252.00M | +44.6% |
| FY2017 | Dec 31, 2017 | $174.30M | +36.3% |
| FY2016 | Dec 31, 2016 | $127.90M | +77.1% |
| FY2015 | Dec 31, 2015 | $72.20M | -47.9% |
| FY2014 | Dec 31, 2014 | $138.50M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$13.80M | -117.5% |
| Q1 FY2026 | Mar 31, 2026 | -$2.00M | -107.9% |
| Q4 FY2025 | Dec 31, 2025 | $97.10M | +50.5% |
| Q3 FY2025 | Sep 30, 2025 | $129.70M | +178.9% |
| Q2 FY2025 | Jun 30, 2025 | $79.00M | +166.0% |
| Q1 FY2025 | Mar 31, 2025 | $25.40M | – |
| Q4 FY2024 | Dec 31, 2024 | $64.50M | +39.6% |
| Q3 FY2024 | Sep 30, 2024 | $46.50M | -55.8% |
| Q2 FY2024 | Jun 30, 2024 | $29.70M | -38.6% |
| Q1 FY2024 | Mar 31, 2024 | -$12.10M | -328.3% |
| Q4 FY2023 | Dec 31, 2023 | $46.20M | -53.1% |
| Q3 FY2023 | Sep 30, 2023 | $105.20M | +5.1% |
| Q2 FY2023 | Jun 30, 2023 | $48.40M | -46.5% |
| Q1 FY2023 | Mar 31, 2023 | $5.30M | -78.2% |
| Q4 FY2022 | Dec 31, 2022 | $98.50M | +29.1% |
| Q3 FY2022 | Sep 30, 2022 | $100.10M | 0.0% |
| Q2 FY2022 | Jun 30, 2022 | $90.50M | +37.5% |
| Q1 FY2022 | Mar 31, 2022 | $24.30M | -52.4% |
| Q4 FY2021 | Dec 31, 2021 | $76.30M | -50.2% |
| Q3 FY2021 | Sep 30, 2021 | $100.10M | +11.2% |
| Q2 FY2021 | Jun 30, 2021 | $65.80M | +34.6% |
| Q1 FY2021 | Mar 31, 2021 | $51.10M | -15.1% |
| Q4 FY2020 | Dec 31, 2020 | $153.30M | +79.3% |
| Q3 FY2020 | Sep 30, 2020 | $90.00M | -24.2% |
| Q2 FY2020 | Jun 30, 2020 | $48.90M | -38.5% |
| Q1 FY2020 | Mar 31, 2020 | $60.20M | – |
| Q4 FY2019 | Dec 31, 2019 | $85.50M | -0.1% |
| Q3 FY2019 | Sep 30, 2019 | $118.70M | +24.6% |
| Q2 FY2019 | Jun 30, 2019 | $79.50M | +29.5% |
| Q1 FY2019 | Mar 31, 2019 | -$8.00M | -182.5% |
| Q4 FY2018 | Dec 31, 2018 | $85.60M | +110.3% |
| Q3 FY2018 | Sep 30, 2018 | $95.30M | +17.8% |
| Q2 FY2018 | Jun 30, 2018 | $61.40M | +32.9% |
| Q1 FY2018 | Mar 31, 2018 | $9.70M | +49.2% |
| Q4 FY2017 | Dec 31, 2017 | $40.70M | -24.3% |
| Q3 FY2017 | Sep 30, 2017 | $80.90M | +113.5% |
| Q2 FY2017 | Jun 30, 2017 | $46.20M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.50M | – |
| Q4 FY2016 | Dec 31, 2016 | $53.80M | – |
| Q3 FY2016 | Sep 30, 2016 | $37.90M | – |
See a number that looks wrong?